Shan-shan Li
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis who have a history of systemic therapies: a post hoc analysis of a phase III trial.
Journal: International immunopharmacology
Published: September 02, 2025
Cutaneous light chain amyloidosis and erythema elevatum diutinum as the presenting features of IgA monoclonal gammopathy: a rare case report and comprehensive literature review.
Journal: Annals of hematology
Published: January 08, 2025
Low-Density Neutrophil Levels Are Correlated with Sporotrichosis Severity: Insights into Subcutaneous Fungal Infection.
Journal: The Journal of investigative dermatology
Published: July 24, 2024
Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer through a moonlighting function.
Journal: Nature communications
Published: March 24, 2024
Hyperthermia is a promising potential adjunct to treating sporotrichosis: A refractory case of HIV sporotrichosis and in vitro experiments on Sporothrix spp.
Journal: Mycoses
Published: August 28, 2023
Erythroderma combined with deeper dermal dermatophytosis due to Trichophyton rubrum in a patient with myasthenia gravis: first case report and literature review.
Journal: BMC infectious diseases
Published: June 21, 2023
Anti-PD-L1 antibody reverses the immune tolerance induced by multiple MUC1-MBP vaccine immunizations by increasing the CD80/PD-L1 ratio, resulting in DC maturation, and decreasing Treg activity in B16-MUC1 melanoma-bearing mice.
Journal: International immunopharmacology
Published: April 10, 2023
Leukocytoclastic Vasculitis Caused by Disseminated Cutaneous Sporotrichosis: A Case Report and Review of the Literature.
Journal: The American Journal of dermatopathology
Published: January 06, 2022
Melanin of Sporothrix globosa affects the function of THP-1 macrophages and modulates the expression of TLR2 and TLR4.
Journal: Microbial pathogenesis
Published: February 18, 2021
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis.
Journal: Chinese medical journal
Published: October 16, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026